Data / Form D filings / Biovantix Biotechnology, Inc
Biovantix Biotechnology, Inc: Form D filings
Biovantix Biotechnology, Inc, a biotechnology company in Dover, DE, filed 2 Form D notices with the SEC in 2025. The latest, on October 17, 2025, reports an offering of $15 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 THE GREEN STE A, Dover, DE, 19901
- Phone
- (714) 365-2391
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2092174
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
| Oct 17, 2025 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christian Carnes | Executive Officer | |
| Jack Sunier | Executive Officer | |
| Elena Verutina | Executive Officer |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biovantix Biotechnology, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.